X4 Pharmaceuticals Inc (XFOR)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | CRAIG, ADAM R | Director, Executive Chairman | Common Stock | Disposal | 47,436 | 4.445 |
| Aug 12, 2026 | VOLPONE, JOHN | President | Common Stock | Disposal | 24,576 | 4.445 |
| Jul 1, 2026 | GOLD, KELLY | Director | Stock Option (right to buy) | Acquisition | 110,000 | 0 |
| Jun 30, 2026 | KIRSKE, DAVID | Chief Financial Officer | Common Stock | Disposal | 8,543 | 4.264 |
| May 12, 2026 | KIRSKE, DAVID | Chief Financial Officer | Common Stock | Disposal | 16,961 | 4.293 |
| Jan 1, 2026 | DE, CRAECKER FRANCOISE | Director | Stock Option (right to buy) | Acquisition | 110,000 | 0 |
| Jan 1, 2026 | STEWART, MURRAY | Director | Stock Option (right to buy) | Acquisition | 110,000 | 0 |
| Jan 1, 2026 | BRIDGER, GARY | Director | Stock Option (right to buy) | Acquisition | 110,000 | 0 |
| Jan 1, 2026 | WYZGA, MICHAEL S | Director | Stock Option (right to buy) | Acquisition | 110,000 | 0 |
| Oct 29, 2025 | KIRSKE, DAVID | Chief Financial Officer | Stock Option (right to buy) | Acquisition | 1,552,769 | 0 |
| Oct 29, 2025 | CRAIG, ADAM R | Director, Executive Chairman | Stock Option (right to buy) | Acquisition | 2,329,154 | 0 |
| Oct 29, 2025 | VOLPONE, JOHN | President | Stock Option (right to buy) | Acquisition | 2,329,154 | 0 |
| Oct 23, 2025 | CRAIG, ADAM R | Director, Executive Chairman | Common Stock | Acquisition | 86,206 | 2.9 |